Literature DB >> 6550481

Penicillin-resistant pneumococcus and meningitis.

G M Caputo, F R Sattler, M R Jacobs, P C Appelbaum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6550481     DOI： 10.7326/0003-4819-98-3-416_2

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

Review 1.  World-wide development of antibiotic resistance in pneumococci.

Authors:  P C Appelbaum
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

2.  In vivo activity and pharmacodynamics of cefotaxime or ceftriaxone in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.

Authors:  P Chavanet; H Beloeil; A Pechinot; F Duigou; J C Buisson; M Duong; C Neuwirth; A Kazmierczak; H Portier
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

Review 3.  Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.

Authors:  M M París; O Ramilo; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

4.  Penicillin-resistant Streptococcus pneumoniae meningitis successfully treated with vancomycin.

Authors:  L M Buzón; A Guerrero; J Romero; J M Santamaria; E Bouza
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

5.  Antibiotic resistance and serotypes of 100 Streptococcus pneumoniae strains isolated in a children's hospital in Barcelona, Spain.

Authors:  C Latorre; T Juncosa; I Sanfeliu
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

Review 6.  Pneumococcal resistance to antibiotics.

Authors:  K P Klugman
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

Review 7.  Infections due to antibiotic-resistant gram-positive cocci.

Authors:  G M Caputo; M Singer; S White; M R Weitekamp
Journal:  J Gen Intern Med       Date:  1993-11       Impact factor: 5.128
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.